Skip to content

Clinical trials

Completed Phase 2 Diabetic Neuropathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Neuropathies Phase: Phase 2 Status: Completed Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20032
20041
20051
20066
20078
20086
20094
20102
20114
20127
20133
20144
20151
20171
20182
20192
20202
20222
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed66

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sangamo Therapeutics4
BioDelivery Sciences International3
SK Life Science, Inc.3
Tris Pharma, Inc.3
AbbVie (prior sponsor, Abbott)2
AstraZeneca2
Aziende Chimiche Riunite Angelini Francesco S.p.A2
Helwan University2
James P. Rathmell, MD2
Sanofi2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Neuropathies66
Diabetes Mellitus19
Pain16
Neuralgia12
Diabetes Mellitus, Type 26
Diabetes Mellitus, Type 15
Chronic Pain4
Peripheral Nervous System Diseases4
Agnosia3
Diabetic Foot2

Trials

Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.